Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 3 » Issue 6
The therapeutic potential of escitalopram in the treatment of panic disorder
Authors Townsend M, Conrad EJ
Published 15 January 2008 Volume 2007:3(6) Pages 835—838
Mark H Townsend, Erich J Conrad
Department of Psychiatry, Louisiana State University Health Sciences Center New Orleans, New Orleans, Louisiana, USA
Abstract: Panic disorder is a chronic and disabling condition that is often accompanied by other psychiatric and medical conditions. The serotonin reuptake inhibitors (SSRIs) and serotoninnorepinephrine reuptake inhibitors (SNRIs) have been used effectively with panic disorder (PD) and conditions in which panic attacks frequently occur. Escitalopram is the most selective SSRI and a variety of evidence suggests it is of great value in the treatment of panic disorder. In this paper, we review the theoretical and practical implications of its use.
Keywords: panic disorder, escitalopram, antidepressant, serotonin
© 2008 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.